• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

计算机断层扫描随访在检测射频消融初始治疗后肝细胞癌复发中的应用:单中心经验。

Computed tomography follow-up for the detection of hepatocellular carcinoma recurrence after initial radiofrequency ablation: a single-center experience.

机构信息

Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.

出版信息

J Vasc Interv Radiol. 2012 Oct;23(10):1269-75. doi: 10.1016/j.jvir.2012.06.032.

DOI:10.1016/j.jvir.2012.06.032
PMID:22999746
Abstract

PURPOSE

Recurrence of hepatocellular carcinoma (HCC) is very common even after curative resection or ablation. This retrospective study compared the radiologic features of recurrent HCC seen by computed tomography (CT) to evaluate our empirical protocol of CT surveillance using 4-month intervals.

MATERIALS AND METHODS

A total of 113 patients who were diagnosed with a first HCC recurrence after radiofrequency (RF) ablation between January 2005 and December 2006 were enrolled at a single center. Definite HCC was defined as hyperattenuation in the arterial phase with washout in the portal venous phase, and a diagnosis of naive and recurrent HCC was based on dynamic CT findings. Recurrent nodules were classified according to the enhancement patterns of previous CT images. The treatment modality for recurrent HCC and survival were evaluated.

RESULTS

One hundred seventy-seven nodules were diagnosed as recurrent HCC: 31 (17.5%) had already been diagnosed on previous CT images as typical HCC, 72 (40.6%) had arterial hypervascularity without washout in the portal venous phase, 21 (11.9%) showed portal venous phase washout without arterial hypervascularity, and no lesions were noted in the remaining 49 (27.7%). Tumor size at recurrence was smaller than 2 cm in diameter in 98 (86.7%) cases. One hundred four patients were treated for recurrent HCC with RF ablation. The 5-year survival rate after recurrence was 49.8%. There was no significant difference in survival among groups divided by the enhancement pattern on the previous CT examination.

CONCLUSIONS

Dynamic CT in 4-month intervals is an acceptable recurrence-monitoring strategy because it detects most recurrent nodules at a stage at which RF ablation is still feasible.

摘要

目的

即使在根治性切除或消融后,肝细胞癌(HCC)的复发也非常常见。本回顾性研究比较了 CT 检查中复发性 HCC 的影像学特征,以评估我们使用 4 个月间隔的 CT 监测经验性方案。

材料与方法

在 2005 年 1 月至 2006 年 12 月期间,我们在一家单中心招募了 113 名接受射频(RF)消融治疗后首次诊断为 HCC 复发的患者。动脉期高强化伴门静脉期洗脱定义为明确 HCC,根据动态 CT 表现诊断为单纯性和复发性 HCC。根据既往 CT 图像的强化模式对复发性结节进行分类。评估复发性 HCC 的治疗方式和生存情况。

结果

诊断为 177 个复发性 HCC 结节:31 个(17.5%)在既往 CT 图像上已经被诊断为典型 HCC,72 个(40.6%)表现为动脉期富血供但无门静脉期洗脱,21 个(11.9%)表现为门静脉期洗脱但无动脉期富血供,49 个(27.7%)未见病灶。98 例(86.7%)复发性 HCC 结节的肿瘤直径均<2cm。104 例患者接受 RF 消融治疗复发性 HCC。复发后 5 年生存率为 49.8%。按既往 CT 检查的强化模式分组,各组之间的生存率无显著差异。

结论

4 个月间隔的动态 CT 是一种可接受的复发监测策略,因为它可以在 RF 消融仍然可行的阶段检测到大多数复发性结节。

相似文献

1
Computed tomography follow-up for the detection of hepatocellular carcinoma recurrence after initial radiofrequency ablation: a single-center experience.计算机断层扫描随访在检测射频消融初始治疗后肝细胞癌复发中的应用:单中心经验。
J Vasc Interv Radiol. 2012 Oct;23(10):1269-75. doi: 10.1016/j.jvir.2012.06.032.
2
Heterogeneous type 4 enhancement of hepatocellular carcinoma on dynamic CT is associated with tumor recurrence after radiofrequency ablation.动态 CT 上表现为异质性 4 型增强的肝细胞癌与射频消融后的肿瘤复发相关。
AJR Am J Roentgenol. 2011 Oct;197(4):W665-73. doi: 10.2214/AJR.11.6843.
3
Contrast-enhanced US-guided radiofrequency ablation of hepatocellular carcinoma.超声造影引导下射频消融治疗肝细胞癌。
J Vasc Interv Radiol. 2013 Aug;24(8):1235-40. doi: 10.1016/j.jvir.2013.04.013. Epub 2013 Jun 21.
4
Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria: according to the recurrence pattern.肝细胞癌最初在米兰标准内根治性切除术后肝内复发的适当治疗策略:根据复发模式
Eur J Gastroenterol Hepatol. 2015 Aug;27(8):933-40. doi: 10.1097/MEG.0000000000000383.
5
Radiofrequency ablation versus hepatic resection for the treatment of hepatocellular carcinomas 2 cm or smaller: a retrospective comparative study.射频消融与肝切除术治疗 2cm 或更小的肝细胞癌:一项回顾性对比研究。
Radiology. 2012 Mar;262(3):1022-33. doi: 10.1148/radiol.11110817.
6
Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection, or radiofrequency ablation?复发性肝细胞癌的治疗策略:挽救性移植、再次切除还是射频消融?
Liver Transpl. 2013 Apr;19(4):411-9. doi: 10.1002/lt.23605. Epub 2013 Mar 17.
7
Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival.钆塞酸二钠磁共振成像对早期肝细胞癌的评估可发现更多病变并提高总体生存率。
Gastroenterology. 2015 Jun;148(7):1371-82. doi: 10.1053/j.gastro.2015.02.051. Epub 2015 Feb 28.
8
[Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy].肝切除术后复发性肝细胞癌的射频消融术
Zhonghua Wai Ke Za Zhi. 2005 Aug 1;43(15):980-4.
9
Repeat radiofrequency ablation provides survival benefit in patients with intrahepatic distant recurrence of hepatocellular carcinoma.重复射频消融术对肝细胞癌肝内远处复发患者的生存有益。
Am J Gastroenterol. 2009 Nov;104(11):2747-53. doi: 10.1038/ajg.2009.414. Epub 2009 Jul 14.
10
Recurrent hepatocellular carcinoma treated with sequential transcatheter arterial chemoembolization and RF ablation versus RF ablation alone: a prospective randomized trial.序贯经导管动脉化疗栓塞和射频消融与单纯射频消融治疗复发性肝细胞癌的前瞻性随机试验。
Radiology. 2012 Feb;262(2):689-700. doi: 10.1148/radiol.11110637. Epub 2011 Dec 12.

引用本文的文献

1
Complementary Role of CEUS and CT/MR LI-RADS for Diagnosis of Recurrent HCC.超声造影与CT/MR LI-RADS在复发性肝癌诊断中的互补作用
Cancers (Basel). 2023 Dec 7;15(24):5743. doi: 10.3390/cancers15245743.
2
Role of gadoxetic acid-enhanced liver magnetic resonance imaging in the evaluation of hepatocellular carcinoma after locoregional treatment.钆塞酸增强肝脏磁共振成像在局部治疗后肝细胞癌评估中的作用。
World J Gastroenterol. 2022 Jul 14;28(26):3116-3131. doi: 10.3748/wjg.v28.i26.3116.
3
[Advances and Challenges of Local Thermal Ablation in Non-small Cell Lung Cancer].
[非小细胞肺癌局部热消融的进展与挑战]
Zhongguo Fei Ai Za Zhi. 2020 Feb 20;23(2):111-117. doi: 10.3779/j.issn.1009-3419.2020.02.06.
4
Safety margin of radiofrequency ablation for hepatocellular carcinoma: a prospective study using magnetic resonance imaging with superparamagnetic iron oxide.肝细胞癌射频消融的安全 margins:一项使用超顺磁性氧化铁磁共振成像的前瞻性研究。 注:原文中的“Safety margin”直译为“安全边际”,结合医学语境这里可理解为“安全范围”等意思,译文采用了更符合医学表达习惯的“安全 margins”(可能是“安全界限”等类似表述,具体准确含义需结合完整医学知识确定) 。
Jpn J Radiol. 2019 Jul;37(7):555-563. doi: 10.1007/s11604-019-00843-1. Epub 2019 May 17.
5
Resection versus ablation for hepatocellular carcinoma: role of initial treatment.肝细胞癌的切除与消融:初始治疗的作用
Hepat Oncol. 2015 Apr;2(2):101-103. doi: 10.2217/hep.15.5. Epub 2015 Apr 20.
6
Therapeutic response assessment of RFA for HCC: contrast-enhanced US, CT and MRI.肝癌射频消融治疗反应评估:超声造影、CT和MRI
World J Gastroenterol. 2014 Apr 21;20(15):4160-6. doi: 10.3748/wjg.v20.i15.4160.
7
Multimodality imaging to assess immediate response to irreversible electroporation in a rat liver tumor model.多模态成像评估不可逆电穿孔治疗大鼠肝肿瘤模型的即刻反应。
Radiology. 2014 Jun;271(3):721-9. doi: 10.1148/radiol.14130989. Epub 2014 Feb 18.
8
Changes in risk of immediate adverse reactions to iodinated contrast media by repeated administrations in patients with hepatocellular carcinoma.肝细胞癌患者重复使用碘对比剂后即刻不良反应风险的变化。
PLoS One. 2013 Oct 2;8(10):e76018. doi: 10.1371/journal.pone.0076018. eCollection 2013.